Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2025-12-24 @ 7:12 PM
NCT ID:
NCT00025103
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of Wilms' tumor or clear cell sarcoma of the kidney, meeting 1 of the following criteria:
* First relapse
* Refractory (progression during first-line therapy)
* Patients in second and subsequent relapses allowed if previously treated with vincristine, dactinomycin, and doxorubicin combination chemotherapy (VCR/DACT/DOX)
* Metachronous tumors in the contralateral kidney allowed if previously treated with VCR/DACT/DOX
* No rhabdoid tumor of the kidney
* Previously treated on UK Wilms' tumor study
PATIENT CHARACTERISTICS:
Age:
* Under 18
Performance status:
* Not specified
Life expectancy:
* Not specified
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* Not specified
PRIOR CONCURRENT THERAPY:
Biologic therapy
* Not specified
Chemotherapy
* See Disease Characteristics
Endocrine therapy
* Not specified
Radiotherapy
* Not specified
Surgery
* Not specified
Other
* See Disease Characteristics
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
17 Years
Study:
NCT00025103
Study Brief:
Protocol Section:
NCT00025103